Diagnostic Products DP
-
S&P drops DP World ratings at port operator's request
DUBAI, May 15 (Reuters) - Standard & Poor's withdrew its credit rating on DP World after the ports operator objected to the way the agency assessed its financial health.
-
Becton, Dickinson and Co: Dividend Stock Analysis
… linked analysis: Company Description: Becton, Dickinson and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs and other settings. Fair Value: In calculating fair value …
-
Hologic (HOLX) agrees to acquire Gen-Probe (GPRO) for ~$3.7B in cash, in the pairing of two smidcap healthcare diagnostics companies. GPRO investors will receive $82.75/share, ~20% above its April 27 ...
… GPRO investors will receive $82.75/share, ~20% above its April 27 closing price. GPRO’s molecular diagnostic products include tests for chlamydia and gonorrhea, as well as human papillomavirus. GPRO +19.3% , HOLX +4.8 …
-
Abbott Labs Completely Overshadows Competitors
… ABT ) is the world's largest company in the nutrition products market and the second largest in the field of diagnostic products . The company has a worldwide customer base, because it not only sells nutritional products but also medical …
-
New Morningstar Analyst Report - Gen-Probe, Inc.
… capitalize on a dramatic upswing in NAT-based cancer diagnostic products as additional biomarkers are discovered and clinically ..... diagnosis and blood screening. The firm markets its clinical diagnostic products , including tests for infectious diseases, to laboratories …
-
New Morningstar Analyst Report - Idexx Laboratories
… bought at a premium to our valuation. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products , equipment, and services for pets and livestock. Its key product lines include single-use canine and feline …
-
Emerging Biomarker Diagnostics: BGMedicine And Vermillion
… cardiovascular disease. Our focus stocks are BGMedicine ( BGMD ) and Vermillion ( VRML ) . Both companies have proprietary diagnostic products being launched this year and resources in the short term to build revenue. We will update news and financial …
-
Johnson & Johnson: The Consumer Division Is Much More Than Just Domestic Brands
… Johnson had sales of $65 billion during 2011 which were mostly derived from pharmaceuticals, medical devices and diagnostic products . The company also has a $14.9 billion consumer division. Sales in this division are split 35% domestic and …
-
BRIEF-Moody's: DP World's 2011 YE results in line with expectations
* Moody's : DP World's 2011 YE results in line with expectations; focus on medium-term capital spending
-
UPDATE 1- DP World 2011 profit rises 82 pct on Australia sale
* Net debt reduced to $3.6 billion (Adds details, CEO comments)